Survey of Ophthalmology
Volume 56, Issue 1 , Pages 86-93 , January 2011

Not Again!

  • Kathryn L. Pepple, MD, PhD

      Affiliations

    • Department of Ophthalmology, Duke University Eye Center and Duke University Medical Center, Durham, North Carolina, USA
    • ,
  • M. Tariq Bhatti, MD

      Affiliations

    • Department of Ophthalmology, Duke University Eye Center and Duke University Medical Center, Durham, North Carolina, USA
    • Department of Medicine (Division of Neurology), Duke University Eye Center and Duke University Medical Center, Durham, North Carolina, USA
    • Corresponding Author InformationReprint address: M. Tariq Bhatti, MD, 2351 Erwin Road, Duke University Eye Center, DUMC 3802, Durham, NC 27710-3802.
    • ,
  • Rod Foroozan, MD

      Affiliations

    • Cullen Eye Institute, Baylor College of Medicine, Houston, Texas, USA

References 

  1. Abu-Amero KK, Milcarek B, Bosley TM. GSTM1 and GSTT1 deletion genotypes in various spontaneous optic neuropathies in Arabs. Br J Ophthalmol. 2009;93:1101–1104
  2. Atkins EJ, Bruce BB, Newman NJ, et al. Treatment of nonarteritic anterior ischemic optic neuropathy. Surv Ophthalmol. 2010;55:47–63
  3. Basile C, Addabbo G, Montanaro A. Anterior ischemic optic neuropathy and dialysis: role of hypotension and anemia. J Nephrol. 2001;14:420–423
  4. Beck RW, Hayreh SS, Podhajsky PA, et al. Aspirin therapy in nonarteritic anterior ischemic optic neuropathy. Am J Ophthalmol. 1997;123:212–217
  5. Beck RW, Savino PJ, Repka MX, et al. Optic disc structure in anterior ischemic optic neuropathy. Ophthalmology. 1984;91:1334–1337
  6. Beck RW, Savino PJ, Schatz NJ, et al. Anterior ischaemic optic neuropathy: recurrent episodes in the same eye. Br J Ophthalmol. 1983;67:705–709
  7. Bendo E, Gilbert M, Foroozan R. Can lightning strike twice?. Surv Ophthalmol. 2008;53:296–300
  8. Bennett JL, Thomas S, Olson JL, et al. Treatment of nonarteritic anterior ischemic optic neuropathy with intravitreal bevacizumab. J Neuroophthalmol. 2007;27:238–240
  9. Berg KT, Nelson B, Harrison AR, et al. Pegylated interferon alpha–associated optic neuropathy. J Neuroophthalmol. 2010 Mar 25;30:117-22
  10. Bernstein SL, Guo Y, Kelman SE, et al. Functional and cellular responses in a novel rodent model of anterior ischemic optic neuropathy. Invest Ophthalmol Vis Sci. 2003;44:4153–4162
  11. Bollinger K, Lee MS. Recurrent visual field defect and ischemic optic neuropathy associated with tadalafil rechallenge. Arch Ophthalmol. 2005;123:400–401
  12. Bosley TM, Abu-Amero KK, Ozand PT. Mitochondrial DNA nucleotide changes in non-arteritic ischemic optic neuropathy. Neurology. 2004;63:1305–1308
  13. Chang SH, Miller NR. The incidence of vision loss due to perioperative ischemic optic neuropathy associated with spine surgery: the Johns Hopkins Hospital Experience. Spine (Phila Pa 1976). 2005;30:1299–1302
  14. Chen CS, Johnson MA, Flower RA, et al. A primate model of nonarteritic anterior ischemic optic neuropathy. Invest Ophthalmol Vis Sci. 2008;49:2985–2992
  15. Cohen S, Gardner F. Bilateral choroidal ischemia in giant cell arteritis. Arch Ophthalmol. 2006;124:922
  16. Deramo VA, Sergott RC, Augsburger JJ, et al. Ischemic optic neuropathy as the first manifestation of elevated cholesterol levels in young patients. Ophthalmology. 2003;110:1041–1046discussion 1046
  17. Doro S, Lessell S. Cup–disc ratio and ischemic optic neuropathy. Arch Ophthalmol. 1985;103:1143–1144
  18. Feit RH, Tomsak RL, Ellenberger C. Structural factors in the pathogenesis of ischemic optic neuropathy. Am J Ophthalmol. 1984;98:105–108
  19. Fingert JH, Grassi MA, Janutka JC, et al. Mitochondrial variant G4132A is associated with familial non-arteritic anterior ischemic optic neuropathy in one large pedigree. Ophthalmic Genet. 2007;28:1–7
  20. Fivgas GD, Newman NJ. Anterior ischemic optic neuropathy following the use of a nasal decongestant. Am J Ophthalmol. 1999;127:104–106
  21. Ganssauge M, Wilhelm H, Bartz-Schmidt KU, Aisenbrey S. Non-arteritic anterior ischemic optic neuropathy (NA-AION) after intravitreal injection of bevacizumab (avastin) for treatment of angoid streaks in pseudoxanthoma elasticum. Graefes Arch Clin Exp Ophthalmol. 2009;247:1707–1710
  22. Giambene B, Sodi A, Sofi F, et al. Evaluation of traditional and emerging cardiovascular risk factors in patients with non-arteritic anterior ischemic optic neuropathy: a case-control study. Graefes Arch Clin Exp Ophthalmol. 2009;247:693–697
  23. Glueck CJ, Wang P. Ocular vascular thrombotic events: a diagnostic window to familial thrombophilia (compound factor V Leiden and prothrombin gene heterozygosity) and thrombosis. Clin Appl Thromb Hemost. 2009;15:12–18
  24. Guhlmann M, Kommerell G. [Simulation of anterior ischemic optic neuropathy by optic nerve sheath meningioma]. Klin Monbl Augenheilkd. 1995;207:200–202
  25. Hayreh SS. In vivo choroidal circulation and its watershed zones. Eye (Lond). 1990;4(Pt 2):273–289
  26. Hayreh SS. The 1994 Von Sallman Lecture. The optic nerve head circulation in health and disease. Exp Eye Res. 1995;61:259–272
  27. Hayreh SS. Role of nocturnal arterial hypotension in the development of ocular manifestations of systemic arterial hypertension. Curr Opin Ophthalmol. 1999;10:474–482
  28. Hayreh SS. Blood flow in the optic nerve head and factors that may influence it. Prog Retin Eye Res. 2001;20:595–624
  29. Hayreh SS. Ischemic optic neuropathy. Prog Retin Eye Res. 2009;28:34–62
  30. Hayreh SS, Fingert JH, Stone E, et al. Familial non-arteritic anterior ischemic optic neuropathy. Graefes Arch Clin Exp Ophthalmol. 2008;246:1295–1305
  31. Hayreh SS, Podhajsky PA, Zimmerman B. Ipsilateral recurrence of nonarteritic anterior ischemic optic neuropathy. Am J Ophthalmol. 2001;132:734–742
  32. Hayreh SS, Zimmerman MB. Non-arteritic anterior ischemic optic neuropathy: role of systemic corticosteroid therapy. Graefes Arch Clin Exp Ophthalmol. 2008;246:1029–1046
  33. Hayreh SS, Zimmerman MB, Podhajsky P, Alward WL. Nocturnal arterial hypotension and its role in optic nerve head and ocular ischemic disorders. Am J Ophthalmol. 1994;117:603–624
  34. Jacobson DM, Vierkant RA, Belongia EA. Nonarteritic anterior ischemic optic neuropathy. A case-control study of potential risk factors. Arch Ophthalmol. 1997;115:1403–1407
  35. Johnson LN, Guy ME, Krohel GB, et al. Levodopa may improve vision loss in recent-onset, nonarteritic anterior ischemic optic neuropathy. Ophthalmology. 2000;107:521–526
  36. Johnson LN, Kuo HC, Arnold AC. HLA-A29 as a potential risk factor for nonarteritic anterior ischemic optic neuropathy. Am J Ophthalmol. 1993;115:540–542
  37. Jonas JB, Spandau UH, Harder B, et al. Intravitreal triamcinolone acetonide for treatment of acute nonarteritic anterior ischemic optic neuropathy. Graefes Arch Clin Exp Ophthalmol. 2007;245:749–750
  38. Kaderli B, Avci R, Yucel A, et al. Intravitreal triamcinolone improves recovery of visual acuity in nonarteritic anterior ischemic optic neuropathy. J Neuroophthalmol. 2007;27:164–168
  39. Kawasaki A, Purvin VA, Burgett RA. Hyperhomocysteinaemia in young patients with non-arteritic anterior ischaemic optic neuropathy. Br J Ophthalmol. 1999;83:1287–1290
  40. Kerr NM, Chew SS, Danesh-Meyer HV. Non-arteritic anterior ischaemic optic neuropathy: a review and update. J Clin Neurosci. 2009;16:994–1000
  41. Kim N, Trobe JD, Flint A, et al. Late ipsilateral recurrence of ischemic optic neuropathy in giant cell arteritis. J Neuroophthalmol. 2003;23:122–126
  42. Knox DL, Kerrison JB, Green WR. Histopathologic studies of ischemic optic neuropathy. Trans Am Ophthalmol Soc. 2000;98:203–220discussion 221–2
  43. Kuhli-Hattenbach C, Scharrer I, Luchtenberg M, et al. [Thrombophilic disorders associated with non-arteritic anterior ischaemic optic neuropathy in patients < 60 years of age]. Klin Monbl Augenheilkd. 2008;225:1065–1069
  44. Kupersmith MJ, Frohman L, Sanderson M, et al. Aspirin reduces the incidence of second eye NAION: a retrospective study. J Neuroophthalmol. 1997;17:250–253
  45. Lapeyraque AL, Haddad E, Andre JL, et al. Sudden blindness caused by anterior ischemic optic neuropathy in 5 children on continuous peritoneal dialysis. Am J Kidney Dis. 2003;42:E3–E9
  46. Laties AM. Vision disorders and phosphodiesterase type 5 inhibitors: a review of the evidence to date. Drug Saf. 2009;32:1–18
  47. Mansour AM, Shoch D, Logani S. Optic disk size in ischemic optic neuropathy. Am J Ophthalmol. 1988;106:587–589
  48. Mojon DS, Hedges TR, Ehrenberg B, et al. Association between sleep apnea syndrome and nonarteritic anterior ischemic optic neuropathy. Arch Ophthalmol. 2002;120:601–605
  49. Newman NJ. Perioperative visual loss after nonocular surgeries. Am J Ophthalmol. 2008;145:604–610
  50. Newman NJ, Scherer R, Langenberg P, et al. The fellow eye in NAION: report from the ischemic optic neuropathy decompression trial follow–up study. Am J Ophthalmol. 2008;134:317–328
  51. Pahor D, Gracner B. [Hyperopia as a risk factor in patients with non-arteritic anterior ischaemic optic neuropathy]. Klin Monbl Augenheilkd. 2008;225:1070–1074
  52. Palombi K, Renard E, Levy P, et al. Non-arteritic anterior ischaemic optic neuropathy is nearly systematically associated with obstructive sleep apnoea. Br J Ophthalmol. 2006;90:879–882
  53. Peter NM, Singh MV, Fox PD. Tadalafil-associated anterior ischaemic optic neuropathy. Eye (Lond). 2005;19:715–717
  54. Pianka P, Almog Y, Man O, et al. Hyperhomocystinemia in patients with nonarteritic anterior ischemic optic neuropathy, central retinal artery occlusion, and central retinal vein occlusion. Ophthalmology. 2000;107:1588–1592
  55. Pomeranz HD, Smith KH, Hart WM, et al. Sildenafil-associated nonarteritic anterior ischemic optic neuropathy. Ophthalmology. 2002;109:584–587
  56. Rizzo JF, Andreoli CM, Rabinov JD. Use of magnetic resonance imaging to differentiate optic neuritis and nonarteritic anterior ischemic optic neuropathy. Ophthalmology. 2002;109:1679–1684
  57. Rizzo JF, Lessell S. Optic neuritis and ischemic optic neuropathy. Overlapping clinical profiles. Arch Ophthalmol. 1991;109:1668–1672
  58. Roth S. Perioperative visual loss: what do we know, what can we do?. Br J Anaesth. 2009;103:i31–i40
  59. Salomon O, Huna-Baron R, Steinberg DM, et al. Role of aspirin in reducing the frequency of second eye involvement in patients with non-arteritic anterior ischaemic optic neuropathy. Eye (Lond). 1999;13(Pt 3a):357–359
  60. Sanjari MS, Falavarjani KG, Mehrabani M, et al. Retrobulbar haemodynamics and carotid wall thickness in patients with non-arteritic anterior ischaemic optic neuropathy. Br J Ophthalmol. 2009;93:638–640
  61. Slater BJ, Mehrabian Z, Guo Y, et al. Rodent anterior ischemic optic neuropathy (rAION) induces regional retinal ganglion cell apoptosis with a unique temporal pattern. Invest Ophthalmol Vis Sci. 2008;49:3671–3676
  62. Worrall BB, Moazami G, Odel JG, et al. Anterior ischemic optic neuropathy and activated protein C resistance. A case report and review of the literature. J Neuroophthalmol. 1997;17:162–165
  63. Yaman A, Selver OB, Saatci AO, et al. Intravitreal triamcinolone acetonide injection for acute non–arteritic anterior ischaemic optic neuropathy. Clin Exp Optom. 2008;91:561–564
  64. Younge BR. Amiodarone and ischemic optic neuropathy. J Neuroophthalmol. 2007;27:85–86
  65. Zhang C, Guo Y, Miller NR, et al. Optic nerve infarction and post-ischemic inflammation in the rodent model of anterior ischemic optic neuropathy (rAION). Brain Res. 2009;1264:67–75

PII: S0039-6257(10)00111-6

doi: 10.1016/j.survophthal.2010.05.002

Survey of Ophthalmology
Volume 56, Issue 1 , Pages 86-93 , January 2011

Article Tools

* Image Usage & Resolution